55F-11786-85132
1 vaccination
1 coded response
11 check-ins
1 free-text entry
1 call case
- Sex
- —
- Age at first dose
- 26-30
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-12
- 2021-04-13
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-17
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-24
- 2021-05-01
- 2021-05-10
- 2021-05-17
- 2021-05-25
- 2021-07-12
-
2022-04-13
Survey response — 12 months, dose 1MedDRA: Asthenia, Bronchitis, COVID-19, Cough, Fatigue, Pulmonary sensitisation, Pyrexia, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID 19 and subsequent bronchitis for five weeks. Fever, fatigue, coughing, breathing problems, sensitive lungs, lack of staminaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-13 | Unsuccessful |
Free text
Release 11 — 12 months, dose 1
Symptoms: COVID 19 and subsequent bronchitis for five weeks. Fever, fatigue, coughing, breathing problems, sensitive lungs, lack of stamina
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pulmonary sensitisation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release